Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update.

Saved in:
Bibliographic Details
Title: Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update.
Authors: Visvanathan K; Johns Hopkins School of Medicine and Johns Hopkins Bloomberg School of Public Health, Baltimore, MD., Fabian CJ; University of Kansas Medical Center, Kansas City, KS., Bantug E; Johns Hopkins School of Medicine, Baltimore, MD., Brewster AM; University of Texas MD Anderson Cancer Center, Houston, TX., Davidson NE; University of Washington, Seattle, WA., DeCensi A; National Hospital E.O. Ospedali Galliera S.C. Oncologia Medica, Genoa, Italy; and Queen Mary University of London, United Kingdom., Floyd JD; Cancer Care Specialists of Illinois, Swansea, IL., Garber JE; Dana-Farber Cancer Institute, Boston, MA., Hofstatter EW; Yale Cancer Center, New Haven, CT., Khan SA; Northwestern University Feinberg School of Medicine, Chicago, IL., Katapodi MC; University of Basel Nursing Science, Basel, Switzerland., Pruthi S; Mayo Clinic Cancer Center, Rochester, MN., Raab R; Cancer Care of Western North Carolina, Asheville, NC., Runowicz CD; Florida International University, Miami, FL., Somerfield MR; American Society of Clinical Oncology, Alexandria, VA.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Nov 20; Vol. 37 (33), pp. 3152-3165. Date of Electronic Publication: 2019 Sep 03.
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.19.01472